Baylor College of Medicine

BLAST Study (H-36486)

Description

Content

Pilot Study of Celecoxib Combined With Gemcitabine and Cisplatin for Neoadjuvant Treatment of Localized, Muscle-Invasive Bladder Cancer

The purpose of this study is to compare patient tumor tissue before and after treatment with standard chemotherapy (gemcitabine+cisplatin) plus celecoxib.

For study details see Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer (BLAST).

Contact

Dr. Edward Yen

Phone 1: 713–798–1354

IRB: H-36486

Status:

Active

Created:

Back to topback-to-top